Specificity of viscumin revised. As probed with a printed glycan array

Biochimie. 2022 Nov:202:94-102. doi: 10.1016/j.biochi.2022.08.009. Epub 2022 Aug 18.

Abstract

Viscumin, a lectin used in anti-cancer therapy, was originally considered as βGal recognizing protein; later, an ability to bind 6'-sialyl N-acetyllactosamine (6'SLN) terminated gangliosides was found. Here we probed viscumin with a printed glycan array (PGA) containing a large number of mammalian sulfated glycans, and found a strong binding to glycans with 6-O-SuGal moiety as lactose, N-acetyllactosamine (LN), di-N-acetyllactosamine (LacdiNAc), and even 6-O-SuGalNAcα (but not SiaTn). Also, the ability to bind some of αGal terminated glycans, including Galα1-3Galβ1-4GlcNAc, was observed. Unexpectedly, only weak interaction was detected with parent neutral β-galactosides including LN-LN-LN and branched (LN)2LN oligolactosamines; in the light of these data, one should not confidently classify viscumin as a β-galactoside-binding lectin. Carrying out PGA in the presence of neutral or sulfated/sialylated glycan, together with sequential elution from lactose-sepharose and consideration of the protein structure, lead to the conclusion that two glycan-binding sites of viscumin have different specificities, one of which prefers charged sulfated and sialylated moieties.

Keywords: Printed glycan array; Sialoglycan; Sulfated glycan; Viscumin; αGal epitope.

MeSH terms

  • Animals
  • Lactose*
  • Mammals
  • Polysaccharides
  • Ribosome Inactivating Proteins, Type 2
  • Sulfates

Substances

  • Lactose
  • mistletoe lectin I
  • Polysaccharides
  • Ribosome Inactivating Proteins, Type 2
  • Sulfates